Inflazome Company Profile

03:02 EDT 20th April 2018 | BioPortfolio

News Articles [5 Associated News Articles listed on BioPortfolio]

Sensorion Seeks Partner For Inner Ear Disorder Drug

Sensorion CEO Nawal Ouzren speaks to Scrip's Lucie Ellis on the sidelines of the recent BIO-Europe partnering meeting about the...    

Appointments: Synthorx, BTG, Pertinax, Realm, Breath, Aerie, iOnctura, Inflazome and NBE

The week's round-up includes a new CEO at Synthorx Inc., new sales executives at Aerie Pharmaceuticals and board appointments at...   

Novartis Champions Cosentyx With More Long-Term Psoriasis Data

Although its focus may be shifting somewhat towards other indications, the Swiss major has reported study read-outs that demonstrate the...    

Busch Out, Moeller Up In Bayer R&D Consolidation; Xofigo Trial Turns Up Safety Issue

Bayer is combining its research and development organization in one unit. Discovery head Andreas Busch is leaving while development head...   

Inflazome Appoints Renowned Harvard Cardiologist to its Scientific Advisory Board

Prof. Paul Ridker joins Inflazome’s Scientific Advisory Board Inflazome Ltd, a biotech company developing small molecule drugs that stop harmful inflammation, today announce...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "Inflazome" on BioPortfolio

We have published hundreds of Inflazome news stories on BioPortfolio along with dozens of Inflazome Clinical Trials and PubMed Articles about Inflazome for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inflazome Companies in our database. You can also find out about relevant Inflazome Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record